BIO-Europe 2008

Nov. 17, 2008-Nov. 19, 2008
Congress Center Rosengarten
Mannheim, Germany
www.ebdgroup.com/bioeurope/

Description:

What Buyers Want: Understanding What Big Pharma In-Licensors Expect to See in Out-Licensing Documents

Ben Bonifant, Vice President and head of our Business Development Practice will lead a panel of pharma licensing and business veterans in analyzing and identifying essential information for compelling out-licensing documents.

Abstract:

What Buyers Want: Understanding What Big Pharma In-Licensors Expect to See in Out-Licensing Documents
 
While the number varies depending on the size of a given therapeutic area, business development professionals at most of the top 10 pharmaceutical and biotech companies review hundreds of non-confidential documents each year to evaluate compounds' in-licensing potential. Out-licensors invest a significant amount of time and resources developing non-confidential documents to help elucidate their products’ attributes in the hope of landing that much-needed deal, but what are the key characteristics of a product or company that lead licensing reviewers to move to confidential discussions?
 
During this interactive roundtable, our panel of pharma licensing and business veterans will
 
  • Share the results of a survey in which senior licensing executives at large pharma and biotech companies were queried on what information they see—and expect to see—in out-licensing documents
  • Provide a comprehensive cost/benefit analysis of how to gather and provide information that is essential to a compelling out-licensing document
  • Share first-hand case examples during a moderated question-and-answer session regarding what they prefer to see in out-licensing documents

View Entire Event Calendar

Don't Miss